Dr. Daniel M. Friedland, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 49 Hooper St., Miles Family Medicine - Wiscasset, Wiscasset, ME 04578 Phone: 207-882-7911 Fax: 207-882-6178 |
Cortney Linville, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 35 Water Str, Wiscasset, ME 04578 Phone: 207-882-6008 Fax: 207-882-7803 |
Dr. Edward B. Kitfield Iii, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 66 Water Str, Wiscasset, ME 04578 Phone: 207-882-6008 Fax: 208-882-7803 |
Dr. Matthew D. Weaver, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 35 Water St, Wiscasset, ME 04578 Phone: 207-882-6008 Fax: 207-882-7803 |
Stephen D. Reed, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 136 Gardiner Rd, Wiscasset, ME 04578 Phone: 207-882-7512 |
News Archive
Using a patient's own stem cells, researchers at Johns Hopkins have corrected the genetic alteration that causes sickle cell disease (SCD), a painful, disabling inherited blood disorder that affects mostly African-Americans. The corrected stem cells were coaxed into immature red blood cells in a test tube that then turned on a normal version of the gene.
Aeterna Zentaris Inc. today announced that perifosine, its oral AKT inhibitor, combined with temsirolimus ("TEM"), was well tolerated in an investigator driven Phase 1 clinical trial in recurrent or progressive malignant glioma ("MG").
After years of detailed study and analysis, the Food and Drug Administration has concluded that meat and milk from clones of cattle, swine, and goats, and the offspring of clones from any species traditionally consumed as food, are as safe to eat as food from conventionally bred animals. There was insufficient information for the agency to reach a conclusion on the safety of food from clones of other animal species, such as sheep.
A drug used to treat asthma has been shown to help reduce the formation of amyloid beta, a peptide in the brain that is implicated in the development of Alzheimer's disease, according to researchers at Temple University's School of Medicine.
A study on the effects of donepezil on people with mild to moderate Alzheimer Disease entitled Long-term donepezil treatment in 565 patients with Alzheimer's Disease(AD2000): randomised double-blind trial appears in the June 26, 2004 issue of The Lancet.
› Verified 6 days ago